FDA initiates regulatory framework for generative AI in medical applications

The FDA is moving to establish oversight for generative AI tools used in healthcare settings, signaling a shift toward formalizing safety standards for algorithmic medical outputs. It remains unclear how stringent these regulations will be or how they will impact existing AI-driven diagnostic and administrative software.